Scinovex
review Open AccessTop 1% cited

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology · 2019 · Vol. 156(5) · pp. 1264–1281.e4
Laurent CastéraMireen Friedrich‐RustRohit Loomba
Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and TransplantationNonalcoholic fatty liver diseaseMedicineDiseaseLiver diseaseFatty liverInternal medicineGastroenterology

MeSH terms

BiopsyHumansLiverLiver CirrhosisLiver Function TestsMagnetic Resonance ImagingMagnetic Resonance SpectroscopyPredictive Value of TestsPrognosisSeverity of Illness IndexUltrasonographyReproducibility of ResultsBiomarkersElasticity Imaging TechniquesNon-alcoholic Fatty Liver Disease

Funding

  • Pfizer
  • Gilead Sciences
  • National Institutes of Health
  • Allergan
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Environmental Health Sciences
Citations
1,418
FWCI
115.12
field-weighted impact
References
221
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease · Scinovex